Skip to content

Gilead Sciences GILD Deferred Taxes

Deferred Taxes at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$211M-23.6%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$30.61M-4.2%
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$156.86B+21.7%
Enterprise value$171.41B+15.5%
P/E17×-3.4×
P/S5.3×+0.8×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's deferred taxes?
Gilead Sciences (GILD) reported deferred taxes of $392M in Q1 2026.
How has Gilead Sciences's deferred taxes changed year-over-year?
Gilead Sciences's deferred taxes decreased by 44.7% year-over-year, from $709M to $392M.
What is the long-term trend for Gilead Sciences's deferred taxes?
Over 5 years (2020 to 2025), Gilead Sciences's deferred taxes has grown at a -36.6% compound annual growth rate (CAGR), from $3.91B to $402M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.